During human cancer tissue screening with the VEGFR2 IHC assay, we characterized the subcellular expression of VEGFR2 in tumor cell membranes, cytoplasm, and nuclei from carcinomas of the lung, breast, cervix, colon, kidney, larynx, ovary, and pancreas. This evidence concerns the gene KDR and carcinoma.